GB9623833D0 - Chemical compound - Google Patents

Chemical compound

Info

Publication number
GB9623833D0
GB9623833D0 GBGB9623833.2A GB9623833A GB9623833D0 GB 9623833 D0 GB9623833 D0 GB 9623833D0 GB 9623833 A GB9623833 A GB 9623833A GB 9623833 D0 GB9623833 D0 GB 9623833D0
Authority
GB
United Kingdom
Prior art keywords
chemical compound
chemical
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9623833.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeneca Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Priority to GBGB9623833.2A priority Critical patent/GB9623833D0/en
Publication of GB9623833D0 publication Critical patent/GB9623833D0/en
Application status is Pending legal-status Critical

Links

GBGB9623833.2A 1996-11-16 1996-11-16 Chemical compound Pending GB9623833D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB9623833.2A GB9623833D0 (en) 1996-11-16 1996-11-16 Chemical compound

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GBGB9623833.2A GB9623833D0 (en) 1996-11-16 1996-11-16 Chemical compound
EP19970912325 EP0941084A1 (en) 1996-11-16 1997-11-12 Raf kinase inhibitors
AU49562/97A AU4956297A (en) 1996-11-16 1997-11-12 Raf kinase inhibitors
PCT/GB1997/003102 WO1998022103A1 (en) 1996-11-16 1997-11-12 Raf kinase inhibitors
CA 2267782 CA2267782A1 (en) 1996-11-16 1997-11-12 Raf kinase inhibitors
JP52331698A JP2001504478A (en) 1996-11-16 1997-11-12 Raf kinase inhibitor
ZA9710314A ZA9710314B (en) 1996-11-16 1997-11-14 Chemical compounds.
NO992336A NO992336D0 (en) 1996-11-16 1999-05-14 Raf kinase inhibitors

Publications (1)

Publication Number Publication Date
GB9623833D0 true GB9623833D0 (en) 1997-01-08

Family

ID=10803023

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9623833.2A Pending GB9623833D0 (en) 1996-11-16 1996-11-16 Chemical compound

Country Status (8)

Country Link
EP (1) EP0941084A1 (en)
JP (1) JP2001504478A (en)
AU (1) AU4956297A (en)
CA (1) CA2267782A1 (en)
GB (1) GB9623833D0 (en)
NO (1) NO992336D0 (en)
WO (1) WO1998022103A1 (en)
ZA (1) ZA9710314B (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772432B2 (en) 1991-09-19 2010-08-10 Astrazeneca Ab Amidobenzamide derivatives which are useful as cytokine inhibitors
AU739066B2 (en) * 1997-09-23 2001-10-04 Astrazeneca Ab Amide derivatives for the treatment of diseases mediated by cytokines
BR9814374B1 (en) * 1997-12-22 2013-09-17 "Heterocyclic substituted ureas and compositions comprising the same"
HU0004426A3 (en) * 1997-12-22 2001-07-30 Bayer Corp Pittsburgh Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas
US6465455B1 (en) * 1998-05-15 2002-10-15 Astrazeneca Ab Benzamide derivatives for the treatment of diseases mediated by cytokines
HU0102295A3 (en) * 1998-05-15 2002-11-28 Astrazeneca Ab Benzamide derivatives for the treatment of diseases mediated by cytokines
AU753741B2 (en) 1998-08-04 2002-10-24 Astrazeneca Ab Amide derivatives useful as inhibitors of the production of cytokines
GB9816837D0 (en) 1998-08-04 1998-09-30 Zeneca Ltd Amide derivatives
NZ509836A (en) 1998-09-25 2003-06-30 Astrazeneca Ab 4-Benzamido-phenyl substitued by an carboxamide derivative useful as a cytokine inhibitor
AT232205T (en) 1998-10-01 2003-02-15 Astrazeneca Ab Quinoline and quinazoline derivatives and which involved cytokine their use as inhibitors of diseases,
US6194399B1 (en) 1998-10-09 2001-02-27 Scriptgen Pharmaceuticals, Inc. Aryldiamine derivatives useful as antibacterial agents
EP2298311B1 (en) 1999-01-13 2012-05-09 Bayer HealthCare LLC w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
RU2284187C2 (en) * 1999-03-17 2006-09-27 Астразенека Аб Derivatives of amide, methods for their preparing, pharmaceutical composition, method of treatment
BR0009083B1 (en) 1999-03-17 2011-11-01 amide derivative comprising a core quinazolinone, process for the preparation of an amide derivative, pharmaceutical composition and use of an amide derivative.
GB9906566D0 (en) 1999-03-23 1999-05-19 Zeneca Ltd Chemical compounds
GB9924092D0 (en) 1999-10-13 1999-12-15 Zeneca Ltd Pyrimidine derivatives
NZ532780A (en) * 2001-12-21 2006-10-27 Wellcome Trust Isolated naturally occurring mutant human B-Raf polypeptides and nucleic acids encoding them
MXPA04007830A (en) 2002-02-11 2005-07-01 Bayer Pharmaceuticals Corp Aryl ureas as kinase inhibitors.
US7838541B2 (en) 2002-02-11 2010-11-23 Bayer Healthcare, Llc Aryl ureas with angiogenesis inhibiting activity
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
WO2004064733A2 (en) * 2003-01-15 2004-08-05 Board Of Regents, University Of Texas System The use of c-raf inhibitors for the treatment of neurodegenerative diseases
ES2305808T3 (en) 2003-05-20 2008-11-01 Bayer Healthcare Llc Diarylureas with kinase inhibitory activity.
US7691870B2 (en) 2003-07-11 2010-04-06 Merck Patent Gmbh Benzimidazole carboxamides as raf kinase inhibitors
CA2532865C (en) 2003-07-23 2013-08-06 Bayer Pharmaceuticals Corporation Fluoro substituted omega-carboxyaryl diphenyl urea for the inhibition of kinase signaling
GB0324790D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Amide derivatives
WO2006007520A1 (en) * 2004-07-01 2006-01-19 Wisconsin Alumni Research Foundation Hydroxybenazamide compounds for treatment of cancer
MX2007002433A (en) * 2004-09-01 2007-05-04 Astrazeneca Ab Quinazolinone derivatives and their use as b-raf inhibitors.
TW200635899A (en) * 2004-12-22 2006-10-16 Astrazeneca Ab Chemical compounds
CA2594860A1 (en) 2005-01-14 2006-07-20 Millennium Pharmaceuticals, Inc. Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
ES2604539T3 (en) * 2005-11-14 2017-03-07 Genentech, Inc. Bisamide type inhibitors of hedgehog signaling
AU2008242697A1 (en) 2007-04-20 2008-10-30 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
EP2569288A2 (en) * 2010-05-11 2013-03-20 Krisani Biosciences (P) Ltd. 4,6-dibenzoylamino-2-methyl-pyrimidine derivatives and their use for the treatment of cancer
US9198911B2 (en) 2010-11-02 2015-12-01 The Trustees Of Columbia University In The City Of New York Methods for treating hair loss disorders
TW201319022A (en) 2011-08-29 2013-05-16 Ticona Llc Aromatic amide compound
WO2013032979A1 (en) 2011-08-29 2013-03-07 Ticona Llc Melt polymerization of low melt viscosity liquid crystalline polymers
JP2014525498A (en) 2011-08-29 2014-09-29 ティコナ・エルエルシー High flow liquid crystalline polymer compositions
US9051514B2 (en) 2011-08-29 2015-06-09 Ticona Llc High flow liquid crystalline polymer composition
WO2013032977A1 (en) 2011-08-29 2013-03-07 Ticona Llc Heat-resistant liquid crystalline polymer composition having a low melting temperature
WO2013032971A1 (en) 2011-08-29 2013-03-07 Ticona Llc Melt-extruded substrate for use in thermoformed articles
WO2013032975A1 (en) 2011-08-29 2013-03-07 Ticona Llc Thermotropic liquid crystalline polymer with improved low shear viscosity
US9045685B2 (en) 2011-08-29 2015-06-02 Ticona Llc Cast molded parts formed from a liquid crystalline polymer
EP2830662B1 (en) 2012-03-29 2018-08-29 The Trustees of Columbia University in the City of New York Methods for treating hair loss disorders
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
WO2014130275A2 (en) 2013-02-22 2014-08-28 Ticona Llc High performance polymer composition with improved flow properties
WO2015041533A1 (en) 2013-09-20 2015-03-26 Stichting Het Nederlands Kanker Instituut Rock in combination with mapk-pathway
WO2015041534A1 (en) 2013-09-20 2015-03-26 Stichting Het Nederlands Kanker Instituut P90rsk in combination with raf/erk/mek
US20170027940A1 (en) 2014-04-10 2017-02-02 Stichting Het Nederlands Kanker Instituut Method for treating cancer
WO2015178770A1 (en) 2014-05-19 2015-11-26 Stichting Het Nederlands Kanker Instituut Compositions for cancer treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993004170A1 (en) * 1991-08-23 1993-03-04 The United States Of America Represented By The Secretary, Department Of Health And Human Services Raf protein kinase therapeutics

Also Published As

Publication number Publication date
WO1998022103A1 (en) 1998-05-28
EP0941084A1 (en) 1999-09-15
NO992336D0 (en) 1999-05-14
JP2001504478A (en) 2001-04-03
AU4956297A (en) 1998-06-10
NO992336L (en) 1999-05-14
ZA9710314B (en) 1998-05-18
CA2267782A1 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
PL209404B1 (en) Aryl-condensed azapolycyclic compounds
GB9714102D0 (en) Compounds
ZA9701645B (en) Chemical compounds.
ZA9708553B (en) Chemical compounds.
ZA9710314B (en) Chemical compounds.
PL338016A1 (en) Novel chemical compounds
ZA9705953B (en) Chemical compounds.
GB9821058D0 (en) Chemical compound
PL336230A1 (en) Novel chemical compounds
GB9412672D0 (en) Chemical compounds
GB9524630D0 (en) Chemical compounds
AU3413397A (en) Supported chemical compound
GB9412573D0 (en) Chemical compounds
GB9412571D0 (en) Chemical compounds
PL338948A1 (en) Chemical compounds
GB9705361D0 (en) Chemical compounds
HRP20000277A2 (en) Chemical compounds
GB9723566D0 (en) Chemical compounds
ZA9807087B (en) Chemical compounds
HRP20000275A2 (en) Chemical compounds
ZA9800702B (en) Chemical compounds
GB9717804D0 (en) Chemical compounds
GB9708611D0 (en) Chemical compounds
AU2369597A (en) Chemical compound
GB9614871D0 (en) Compounds